Literature DB >> 1885733

Fine serotyping of human immunodeficiency virus serotype 1 (HIV-1) and HIV-2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV-1 and HIV-2/simian immunodeficiency virus.

A Baillou1, B Janvier, G Leonard, F Denis, A Goudeau, F Barin.   

Abstract

In this study, enzyme immunoassays for detection of type-specific antibodies to human immunodeficiency viruses (HIV) were developed by using short peptides corresponding to sequences located within the immunodominant domain of the transmembrane glycoproteins of both HIV-1 and HIV-2-simian immunodeficiency virus (SIV). The assays were highly sensitive with currently available sera from various geographical areas. Furthermore, they appeared to be more specific in HIV serotyping than the Western blot (immunoblot) assay, since all of the sera were clearly discriminated as one or the other type. It was also shown that in contrast to HIV-1, the C-terminal cysteine residue (amino acid 620, SIV from captive macaques, Mm142 strain) of the HIV-2-SIV peptide is not necessary for recognition of the peptide by antibody to HIV-2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885733      PMCID: PMC270123          DOI: 10.1128/jcm.29.7.1387-1391.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.

Authors:  J W Gnann; J A Nelson; M B Oldstone
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

3.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

4.  Isolation of a new human retrovirus from West African patients with AIDS.

Authors:  F Clavel; D Guétard; F Brun-Vézinet; S Chamaret; M A Rey; M O Santos-Ferreira; A G Laurent; C Dauguet; C Katlama; C Rouzioux
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

5.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

Authors:  J J Wang; S Steel; R Wisniewolski; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Human B-cell epitopes of HIV-2 transmembrane protein are similarly spaced as in HIV-1.

Authors:  J Goudsmit; R H Meloen; R Brasseur; F Barin
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

7.  An African primate lentivirus (SIVsm) closely related to HIV-2.

Authors:  V M Hirsch; R A Olmsted; M Murphey-Corb; R H Purcell; P R Johnson
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

8.  Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.

Authors:  P J Kanki; S M'Boup; D Ricard; F Barin; F Denis; C Boye; L Sangare; K Travers; M Albaum; R Marlink
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

9.  Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast.

Authors:  F Denis; F Barin; G Gershy-Damet; J L Rey; M Lhuillier; M Mounier; G Leonard; A Sangare; A Goudeau; S M'Boup
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

10.  The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein.

Authors:  V Hirsch; N Riedel; J I Mullins
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

View more
  4 in total

1.  Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Authors:  Francis Barin; Laurence Meyer; Rémi Lancar; Christiane Deveau; Myriam Gharib; Anne Laporte; Jean-Claude Desenclos; Dominique Costagliola
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis.

Authors:  J D Fontenot; E A Hoover; J H Elder; R C Montelaro
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

3.  Simple enzyme immunoassay for titration of antibodies to the CD4-binding site of human immunodeficiency virus type 1 gp120.

Authors:  I Turbica; M Posner; C Bruck; F Barin
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

4.  Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.

Authors:  J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.